Mothers who use methamphetamine during pregnancy can transfer the drug through the placenta to their babies, according to a report in the September issue of the Archives of Disease in Childhood. Fetal and Neonatal Edition.
Mothers who use methamphetamine during pregnancy can transfer the drug through the placenta to their babies, according to a report in the September issue of the Archives of Disease in Childhood. Fetal and Neonatal Edition.
Facundo Garcia-Bournissen, MD, of the University of Toronto in Ontario, Canada, and colleagues analyzed hair samples referred to their laboratory for drug testing from hospitals throughout Canada between 1997 and 2005. The survey included more than 34,000 tests representing more than 8,000 individuals.
The investigators found that 396 individuals and 11 mother-baby pairs tested positive for methamphetamine. Levels of the drug in mothers and neonates correlated significantly. Of the 171 individuals who tested positive for methamphetamine and who were also tested for other drugs of abuse, 83.5% tested positive for at least one other drug (65% for cocaine, 37.6% for marijuana and 30.2 % for opiates).
“Because neonatal hair grows in the last trimester of pregnancy, a positive hair test for methamphetamine in the baby is a biomarker of maternal addiction, as the mother has long known she is pregnant by the seventh month of pregnancy,” the authors write.
Garcia-Bournissen F, Rokach B, Karaskov T, et al. Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. Arch Dis Child Fetal Neonatal Ed. 2007;92:F351-F355.
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More